https://www.marketscreener.com/quote/stock/SILENCE-THERAPEUTICS-PLC-111895683/news/Silence-Therapeutics-Completes-Enrollment-in-Phase-2-Study-of-Zerlasiran-in-Subjects-with-Elevated-L-43709495/?utm_source=telegram&utm_medium=social&utm_campaign=share